Endexx Corporation (OTC PINK: EDXC), a provider of innovative hemp derived phyto-nutrients and nutritional products, today announced the launch of a doctor supervised, adaptive clinical study to test the efficacy of its proprietary CBD capsule in response to patients suffering from neuropathic pain.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.